| Target Price | $249.90 |
| Price | $96.99 |
| Potential |
157.66%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Inhibrx Inc 2027 .
The average Inhibrx Inc target price is $249.90.
This is
157.66%
register free of charge
$341.25
251.84%
register free of charge
$232.30
139.51%
register free of charge
|
|
| A rating was issued by 10 analysts: 8 Analysts recommend Inhibrx Inc to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Inhibrx Inc stock has an average upside potential 2027 of
157.66%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -9.04 | -9.99 |
| 108.03% | 10.51% | |
| P/E | negative |
5 Analysts have issued a Inhibrx Inc forecast for earnings per share. The average Inhibrx Inc EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 24 2026 |
| Stifel |
Locked
➜
Locked
|
Locked | Apr 08 2026 |
| JMP Securities |
Locked
➜
Locked
|
Locked | Aug 22 2025 |
| JMP Securities |
Locked
➜
Locked
|
Locked | May 15 2025 |
| Citizens Capital Markets |
Locked
➜
Locked
|
Locked | Mar 18 2025 |
| JMP Securities |
Locked
➜
Locked
|
Locked | Jan 22 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 24 2026 |
|
Locked
Stifel:
Locked
➜
Locked
|
Apr 08 2026 |
|
Locked
JMP Securities:
Locked
➜
Locked
|
Aug 22 2025 |
|
Locked
JMP Securities:
Locked
➜
Locked
|
May 15 2025 |
|
Locked
Citizens Capital Markets:
Locked
➜
Locked
|
Mar 18 2025 |
|
Locked
JMP Securities:
Locked
➜
Locked
|
Jan 22 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


